These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 31625123)
21. Proline-rich protein 11 silencing inhibits hepatocellular carcinoma growth and epithelial-mesenchymal transition through β-catenin signaling. Qiao W; Wang H; Zhang X; Luo K Gene; 2019 Jan; 681():7-14. PubMed ID: 30248355 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling. Quan H; Li B; Yang J Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536 [TBL] [Abstract][Full Text] [Related]
24. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway. Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010 [TBL] [Abstract][Full Text] [Related]
25. NLRC5 regulates cell proliferation, migration and invasion in hepatocellular carcinoma by targeting the Wnt/β-catenin signaling pathway. Peng YY; He YH; Chen C; Xu T; Li L; Ni MM; Meng XM; Huang C; Li J Cancer Lett; 2016 Jun; 376(1):10-21. PubMed ID: 26975630 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Zhou M; Zhang XY; Yu X Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259 [TBL] [Abstract][Full Text] [Related]
27. EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β-catenin signaling. Li Z; Xue TQ; Yang C; Wang YL; Zhu XL; Ni CF J Cell Biochem; 2018 Dec; 119(12):10327-10337. PubMed ID: 30129142 [TBL] [Abstract][Full Text] [Related]
28. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1. Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131 [TBL] [Abstract][Full Text] [Related]
29. LncRNA GHET1 predicts poor prognosis in hepatocellular carcinoma and promotes cell proliferation by silencing KLF2. Jin L; He Y; Tang S; Huang S J Cell Physiol; 2018 Jun; 233(6):4726-4734. PubMed ID: 29139562 [TBL] [Abstract][Full Text] [Related]
30. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
31. Downregulation of RIP140 in hepatocellular carcinoma promoted the growth and migration of the cancer cells. Zhang D; Wang Y; Dai Y; Wang J; Suo T; Pan H; Liu H; Shen S; Liu H Tumour Biol; 2015 Mar; 36(3):2077-85. PubMed ID: 25391428 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway. Bai Z; Xia X; Lu J Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma. Zhou Q; Zhang W; Wang Z; Liu S BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767 [TBL] [Abstract][Full Text] [Related]
34. LncAY controls BMI1 expression and activates BMI1/Wnt/β-catenin signaling axis in hepatocellular carcinoma. Chen MH; Fu LS; Zhang F; Yang Y; Wu XZ Life Sci; 2021 Sep; 280():119748. PubMed ID: 34174322 [TBL] [Abstract][Full Text] [Related]
35. Tumor suppressor role of sFRP‑4 in hepatocellular carcinoma via the Wnt/β‑catenin signaling pathway. Wu Q; Xu C; Zeng X; Zhang Z; Yang B; Rao Z Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760186 [TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition. Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828 [TBL] [Abstract][Full Text] [Related]
37. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes. Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133 [TBL] [Abstract][Full Text] [Related]
38. UNC119 promotes the growth and migration of hepatocellular carcinoma via Wnt/β/catenin and TGF/β-EMT signaling pathways. Liu Z; Zhang Y; Xu Z J BUON; 2018; 23(1):188-192. PubMed ID: 29552782 [TBL] [Abstract][Full Text] [Related]
39. microR-505/heterogeneous nuclear ribonucleoprotein M inhibits hepatocellular carcinoma cell proliferation and induces cell apoptosis through the Wnt/β-catenin signaling pathway. Chi X; Jiang Y; Chen Y; Lv L; Chen J; Yang F; Zhang X; Pan F; Cai Q Biomark Med; 2020 Jul; 14(11):981-996. PubMed ID: 32940078 [No Abstract] [Full Text] [Related]
40. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways. Han K; Li C; Zhang X; Shang L Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]